Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INTERFERON BETA-1B for Relapsing multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15 adverse event reports in the FDA FAERS database where INTERFERON BETA-1B was used for Relapsing multiple sclerosis.

Most Reported Side Effects for INTERFERON BETA-1B

Side Effect Reports % Deaths Hosp.
Multiple sclerosis relapse 1,229 10.0% 12 312
Influenza like illness 1,042 8.4% 1 110
Injection site pain 1,014 8.2% 3 122
Fatigue 783 6.3% 9 130
Drug ineffective 767 6.2% 7 53
Injection site erythema 724 5.9% 1 73
Injection site reaction 707 5.7% 0 86
Pain 597 4.8% 6 115
Headache 596 4.8% 6 134
Multiple sclerosis 589 4.8% 24 116
Gait disturbance 525 4.3% 7 157
Death 501 4.1% 501 41
Injection site bruising 480 3.9% 0 32
Pyrexia 475 3.9% 10 135
Chills 460 3.7% 3 69

Other Indications for INTERFERON BETA-1B

Multiple sclerosis (7,192) Product used for unknown indication (842) Relapsing-remitting multiple sclerosis (694) Secondary progressive multiple sclerosis (146) Covid-19 (93) Multiple sclerosis relapse (28) Chronic myeloid leukaemia (26) Clinically isolated syndrome (18) Covid-19 pneumonia (16) Hepatitis c (13)

Other Drugs Used for Relapsing multiple sclerosis

OCRELIZUMAB (6,883) OFATUMUMAB (3,705) FINGOLIMOD (851) GLATIRAMER (375) ALEMTUZUMAB (350) SIPONIMOD (194) INTERFERON BETA-1A (192) NATALIZUMAB (140) RITUXIMAB (136) OZANIMOD (127)

Related Pages

INTERFERON BETA-1B Full Profile All Relapsing multiple sclerosis Drugs INTERFERON BETA-1B Demographics INTERFERON BETA-1B Timeline